cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0001551,C0518609,NEG_TREATS,Immunologic Adjuvants,Consideration,imft,fndg,1,NEG_TREATS_IMFTntrtsFNDG
C0025010,C2220378,NEG_TREATS,Measles Vaccine,severe Allergic disorders,imft,fndg,1,NEG_TREATS_IMFTntrtsFNDG
C0887894,C1545588,NEG_TREATS,Respiratory Syncytial Virus Vaccines,Protection,imft,fndg,1,NEG_TREATS_IMFTntrtsFNDG
C2825347,C4321237,NEG_TREATS,"immunoglobulin A, human",High Level,imft,fndg,1,NEG_TREATS_IMFTntrtsFNDG
C2825347,C4747995,NEG_TREATS,"immunoglobulin A, human",Nasal secretions,imft,fndg,1,NEG_TREATS_IMFTntrtsFNDG
C3272757,C0085393,NEG_TREATS,Live Attenuated Influenza Vaccine,Immunocompromised Host,imft,fndg,1,NEG_TREATS_IMFTntrtsFNDG
